Skip to main content

Avricore Health Inc.

corporate_fare Company Profile

Avricore Health Inc.

AVCRF·OTC·Life Sciences·CIK 0001355736

Duft Biotech Capital Ltd. was incorporated on May 30, 2000, under the BC Companies Act. The company was classified as a Capital Pool Company ("CPC") on the TSX Venture Exchange. As a CPC, its primary business was to identify and evaluate acquisition opportunities, with the completion of such an acquisition referred to as a Qualifying Transaction. A CPC does not conduct any business operations or hold assets other than seed capital, and it does not have agreements for asset or business acquisition at its formation. A Qualifying Transaction, as defined by TSX Venture Exchange policies, involves a capital pool company either issuing common shares or convertible securities representing over 25 percent of its outstanding common shares for significant assets or businesses, entering into an arrangement where another issuer's security holders gain control of the resulting entity, or otherwise acquiring significant non-cash assets. On November 13, 2003, the company acquired the assets of ALDA Pharmaceuticals Inc. ("API"), a private company established in 1996.

Avricore Health Inc. (OTC:AVCRF) is a publicly traded company in the Life Sciences sector. Wiseek monitors AVCRF SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Avricore Health Closes Upsized $1.254M Private Placement with Insider Participation
  • Avricore Health Secures $1.25M Private Placement to Address Going Concern
  • Avricore Health Faces Going Concern Warning Amidst 89% Revenue Drop and Increased Losses
  • Avricore Health's HealthTab™ Expands to 70 New Pharmacy Sites in North East London NHS Program
  • Avricore Health Reports Steep Revenue Decline and Going Concern Warning Amid Major Customer Loss

Financial Snapshot

Fiscal year ended December 31, 2024
Revenue
CA$4.66M CAD
Net Income
-CA$668.98K CAD
Diluted EPS
-CA$0.01 CAD
Op. Cash Flow
CA$1M CAD
Free Cash Flow
CA$823.52K CAD
Gross Profit
CA$1.88M CAD
Cash & Equivalents
CA$1.13M CAD
Debt / Equity
0.00×
Net Margin
-14.4%
Source: 20-F · filed 2025-06-16 · accession 0001641172-25-015266

Dilution Risk

Low risk

Filing-implied dilution signals for AVCRF, detected from its recent SEC filings · based on capital-structure filings through 2026-07-11.

Private Placement Closed · Insider Participation

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

AVCRF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with A →
$0.025
52-week range · as of 2026-07-11 $0.0151 – $0.0787
Market cap
$2.53M
Volume
20K (0.3× avg)
3-mo avg 60.3K
Live data · 2026-07-29 10:32 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed AVCRF - Latest Insights

AVCRF
Jul 10, 2026, 8:19 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.056
Real-time Price: $0.025 info
Change: -$0.031 (-55%) info
Market Cap: $2.532M info
AVCRF
Jun 11, 2026, 6:12 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.04965
Real-time Price: $0.025 info
Change: -$0.02465 (-50%) info
Market Cap: $2.532M info
AVCRF
May 08, 2026, 7:01 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.0399
Real-time Price: $0.025 info
Change: -$0.0149 (-37%) info
Market Cap: $2.532M info
AVCRF
Feb 17, 2026, 6:15 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.0529
Real-time Price: $0.025 info
Change: -$0.0279 (-53%) info
Market Cap: $2.532M info
AVCRF
Jan 12, 2026, 3:09 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.03525
Real-time Price: $0.025 info
Change: -$0.01025 (-29%) info
Market Cap: $2.532M info